Urinary Incontinence , StressNCT07597174
Mobile App vs. In-Person Pelvic Floor Rehabilitation for Urinary Leakage in Adult Women
A study testing Mobile app based rehabilitation protocol and Presential rehabilitation program in people with Urinary Incontinence , Stress, run by Unidade Local de Saúde São João, Oporto at 1 site in Portugal.
Trial summary
The goal of this clinical trial is to learn if a mobile app-guided pelvic floor rehabilitation program works as well as standard in-person pelvic floor rehabilitation to treat urinary leakage in adult women. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Urinary Incontinence , Stress
- What is being tested?
- Mobile app based rehabilitation protocol and Presential rehabilitation program
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 1 sitePortugal
- Study dates
- 26 Mar 2026to 21 Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- age >18 years
- stress urinary incontinence (SUI) or mixed urinary incontinence with predominance of SUI
- more than one urinary incontinence episode for week in the last month
- pelvic floor muscle strength equal or greater than 2 assessed by Oxford Modified Rating Score
Who cannot join
- indwelling urinary catheter
- active pelvic neoplasia
- pelvic organ prolapse grade greater than or equal to 2
- active urinary tract infection or macroscopic hematuria
- neurogenic dysfunction of the lower urinary tract
- cognitive deficit, osteoarticular, neurological or psychiatric pathologies that prevent the realization of the therapeutic program
Show all 10Show fewer
- conservative or surgical treatment of UI in the last 12 months
- pregnancy or recent childbirth (< 6 months)
- impossibility of access or illiteracy to technological means (smartphone)
- unavailability to attend the supervised program due to accessibility, schedule or economic reasons
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Randomized Controlled Non-Inferiority Trial Comparing a Mobile Application Based Program With Conventional Rehabilitation for Stress and Mixed Urinary Incontinence in Adult Women
The goal of this clinical trial is to learn if a mobile app-guided pelvic floor rehabilitation program works as well as standard in-person pelvic floor rehabilitation to treat urinary leakage in adult women.
The main question it aims to answer is:
Read more
Does the app program improve quality of life related to urinary leakage as much as in-person rehabilitation?
Researchers will compare the app-based program to in-person rehabilitation to see if both lead to similar improvements in quality of life.
Participants will:
Attend one medical visit before starting to confirm they are eligible Attend one in-person training session with a physiotherapist Follow either an app-based or an in-person pelvic floor rehabilitation program for 3 months Complete quality of life questionnaires at the start and at 4 months
Read the detailed description
Background
Urinary incontinence (UI) is common in women and undertreated in Portugal. Only 11% of Portuguese women with UI report having completed any rehabilitation program. Conventional pelvic floor rehabilitation requires supervised sessions two to three times per week for at least 3 to 4 months, mostly available only at tertiary hospitals. Mobile app-based programs may improve access, adherence, and convenience. However, no randomized trial has compared an app-based program directly against supervised rehabilitation as an active comparator in the Portuguese population. An important consideration in participant selection is pelvic floor muscle function. Studies show that up to 53% of women with UI cannot contract the pelvic floor correctly without prior in-person training. For this reason, the ability to voluntarily contract the pelvic floor is an inclusion criterion, confirmed at the baseline medical visit.
Study Design
This is a randomized controlled non-inferiority trial with two parallel arms conducted at the Pelvic Floor Rehabilitation Unit of the Physical and Rehabilitation Medicine (PM\&R) Department of ULS São João, a tertiary academic hospital in Porto, Portugal.
The Mobile App
The app-based program was developed by the investigators in collaboration with the Information Systems and Technologies Department and the Data Intelligence Department of ULS São João. It was integrated into the existing My São João App, a platform already in use by patients of the hospital. Prior to the trial, a preliminary version was tested over one month with 10 women with prior experience in supervised pelvic floor rehabilitation and with 4 clinicians specialised in pelvic floor rehabilitation. Participants completed a structured questionnaire assessing interface usability, aesthetics, engagement, and functionality, and took part in a discussion of weaknesses and suggestions for improvement. A final version was developed based on this feedback.
Randomization
After baseline assessment, participants are randomized 1:1 into the intervention or control group by a research assistant not involved in the investigation. Allocation uses a computer-generated random sequence implemented through sequentially numbered sealed opaque envelopes, stored in a locked cabinet accessible only to the research assistant. Envelopes are opened immediately before the initial individual session. Participants and health professionals are not blinded to group allocation.
Intervention Group - App-Based Program (12 weeks)
One in-person medical consultation at the start. Participants install the app, are trained on its use, and receive lifestyle and behavioural recommendations tailored to their UI type and baseline assessment results. Three in-person individual physiotherapy sessions at weeks 0, 4, and 8. At each session, participants are trained on the exercises that will be released on the app following that session. App content includes a structured pelvic floor muscle exercise program released in 3 progressive phases, with gradual increases in duration, repetitions, and positions. Participants perform a daily sequence 3 times per day and two 30-minute sessions per week. Programmable reminders allow participants to set exercise times according to their own schedule. Daily app notifications collect feedback on the number of sessions completed and participant satisfaction. One teleconsultation at week 6 to assess adherence, motivation, side effects, and progress. At week 12, participants are notified via the app to begin the maintenance phase: the daily sequence 3 times per day, 3 days per week. One in-person medical consultation at week 16 to assess compliance and outcomes.
Control Group - Supervised Program (12 weeks)
One in-person medical consultation at the start. Participants receive lifestyle and behavioural recommendations tailored to their UI type and baseline assessment results, and a written leaflet with a pelvic floor exercise sequence to perform 3 times per day. One initial in-person individual physiotherapy session, followed by supervised face-to-face group sessions twice per week (30 minutes each), structured in 3 progressive phases matching those of the app program. One in-person medical consultation at week 6 to assess adherence, side effects, and progress. At week 12, participants are instructed to begin the maintenance phase: 3 exercise sets, 3 days per week. One in-person medical consultation at week 16 to reassess compliance and outcomes.
Assessment Schedule
Outcomes are collected by physiatrists specialised in pelvic floor rehabilitation using a digital data collection form at three time points: baseline (week 0), mid-program (week 6), and end of follow-up (week 16).
Sample Size
Sample size was calculated using WinPepi version 11.65, assuming a significance level of 5%, statistical power of 80%, and a 1:1 allocation ratio. Based on a non-inferiority margin of 10.24 points on the King's Health Questionnaire (KHQ), with standard deviations of 10.545 (intervention) and 6.23 (control), 24 participants are required (12 per group). Accounting for an estimated 33% dropout rate, the target sample is 32 participants.
Statistical Analysis
Continuous variables will be described as means with standard deviations, or medians with interquartile ranges, depending on distribution. Categorical variables will be presented as proportions. Between-group comparisons at end of program will use the independent-samples t-test for normally distributed data, or the Mann-Whitney test otherwise. Categorical variables will be compared using the Chi-square or Fisher's exact test as appropriate. A pre-specified subgroup analysis will examine adherence and clinical improvement according to age, primary diagnosis (SUI or MUI), prior treatments, condition severity, quality of life scores, marital status, educational level, profession, smartphone operating system, duration of smartphone ownership, daily hours of use, and prior experience with health-related apps. A subsequent cost-effectiveness analysis is planned.
Ethical Considerations
The study is conducted in accordance with the ethical principles of the 1964 Declaration of Helsinki and its subsequent amendments. Participation is voluntary. Eligible participants are approached at their first consultation and given a participant information sheet and written informed consent form to take home. Signed consent is confirmed at the second appointment, two weeks later. Participants may withdraw at any time without consequence. All data are anonymised prior to analysis and stored securely with password protection. Only the participant's physiatrist has access to medical records. Results will be disseminated at scientific conferences and in peer-reviewed journals.
- Conditions
- Urinary Incontinence , Stress
- Being tested
- Mobile app based rehabilitation protocol, Presential rehabilitation program
- Keywords
- mobile app, urinary incontinence, woman
- Medical subject headings
- Urinary Incontinence, Stress, Urinary Incontinence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mobile app based rehabilitation protocolOther
Mobile app based rehabilitation protocol for Stress and Mixed Urinary Incontinence in Adult Women
Presential rehabilitation programOther
Presential rehabilitation program for Stress and Mixed Urinary Incontinence in Adult Women
| Study group | Role | What they receive |
|---|---|---|
| Hybrid | Experimental | mobile app based treatment Receives: Other: Mobile app based rehabilitation protocol |
| conventional | Active comparator | presential Receives: Other: Presential rehabilitation program |
What is being measured
The primary outcome is the main question the study is designed to answer.
UI-related quality of life
UI-related quality of life using the Portuguese version of the King´s Health Questionnaire (KHQ). KHQ is a disease-specific, self-administered questionnaire designed to assess the impact of UI on quality of life in women. The responses in KHQ have a four point rating system. The eight subscales ("domains") score between 0 (best) and 100 (worst). The Symptom Severity scale is scored from 0 (best) to 30 (worst). Decreases in KHQ domain scores indicate an improvement in quality of life. The minimally important difference - the smallest change in score that subjects perceive as beneficial - is 3 points for the symptom severity scale and 5 points for all other KHQ domains.
Measured: At baseline and in16 weeks
Secondary outcomes (8)
UI severity
UI severity using: the ICS pad test, the Portuguese versions of the ICIQ-bladder diary, and of the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF). The ICS pad test has been standardized by the International Continence Society and implies drinking 500mL of water and performing a protocol of activities during 1 hour. The total amount of urine leaked is determined by weighing the pad at the end. A weight difference of 1g is considered as significative. The ICIQ-bladder diary is a standardised diary that includes records of the number of incontinence episodes. The ICIQ-UI Short Form is a self-administered questionnaire for evaluating the frequency, severity and impact on quality of life of UI. It contains 4 items: frequency of urinary incontinence; amount of leakage; overall impact of urinary incontinence; self-diagnostic item. It is scored from 0 (best) to 21 (worst), considering 2.5 points for a minimal clinically important difference.
Measured: At baseline and in16 weeks
Perception of change
Perception of change by the patient using the Portuguese version of the Patient Global Impression of Change (PGIC) Scale. The PGIC Scale is is a global index that may be used to rate the response of a condition to a therapy. It is a transition scale consisting of a single question asking the patient to rate their urinary tract condition now, as compared with how it was prior to beginning treatment on a scale from 1 (Very much better) to 7 (Very much worse).
Measured: At baseline and in16 weeks
Sexual function
Sexual function using the Portuguese version of the Female Sexual Functioning Index (FSFI). The FSFI is a survey measuring the sexual functioning of women over the previous 30 days in six different domains: desire, arousal, lubrication, orgasm, satisfaction and pain. Sexual disfunction severity is classified into five categories based on FSFI total scores: severe (2-7.2), moderate (7.3-14.4), mild to moderate (14.5-21.6), mild (21.7-28.1 "cutoff value"), and no sexual disfunction (28.2-36).
Measured: At baseline and in16 weeks
Symptoms of depression/anxiety
Symptoms of depression/anxiety using the Portuguese version of the Hospital Anxiety \& Depression Scale (HADS) questionnaire. HADS is a fourteen-item scale with seven items each for anxiety and depression subscales. Scoring for each item ranges from zero to three. A subscale score >8 denotes anxiety or depression.
Measured: At baseline and in 16 weeks
Health related quality of life
Health related quality of life, using the Portuguese version of the EuroQol 5-Dimension 5-level (EQ-5D-5L) questionnaire. The EQ-5D-5L is a brief, generic, health status measure composed of 5 questions with Likert response options (descriptive system) and a visual analog scale (EQ-VAS). The latter asks patients to rate their own health from 0 to 100 (the worst and best imaginable health, respectively). The VAS can be used as a quantitative measure of health outcome that reflects the patient's own judgement. EQ-5D utility values can be used to calculate QALYs, which can then be used in cost-utility analysis.
Measured: At baseline and in 16 weeks
Satisfaction and adherence to treatment .
Satisfaction and adherence to treatment using a 9-point Likert scale and the self-reported number of performed sessions registered in the app (intervention group) and reported by the therapist (control group).
Measured: At 16 weeks
Participants assessment of the app quality
Participants assessment of the app quality using the Portuguese version of the User Mobile App Rating Scale (uMARS). The uMARS provides 20 items in a total of 5 subscales, 4 objective quality subscales - Engagement, Functionality, Aesthetics and Information Quality - and 1 subjective quality subscale that adds 6 items to measure the impact perceived by users of the evaluated application. All items are rated on a 5-point scale from "1. Inadequate" to "5. Excellent"; there is an option to select "N/A" if the application component is irrelevant. The quality score is calculated as follows: App Quality Mean Score = (A+B+C+D)/4, where A: Engagement Mean Score; B: Functionality Mean Score; C: Aesthetics Mean Score; D: Information Mean Score. Questions rated "N/A" are excluded from the mean score calculation. Total mean score reflects the overall app quality, higher scores indicate a better user experience.
Measured: 16 weeks
Direct costs of urinary incontinence
Direct costs of urinary incontinence with an adapted version of the Dowell-Bryant Incontinence Cost Index (DBICI). The DBICI gives a detailed measure of the direct economic costs of urinary incontinence in ambulatory home-dwelling women, with the construct validity confirmed by the significant correlation with other quantitative measures of incontinence. By substituting local prices into the test format, the index can be used in different countries.
Measured: At baseline and in16 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2026
- Study start26 Mar 2026
- Primary completion21 Aug 2026 (estimated)
- Study completion21 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Urinary Incontinence , StressStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- randomized controlled non-inferiority trial with two parallel arms
- Masking
- None (open label)
- Enrolment
- 32 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Unidade Local de Saúde São João, Oporto
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Susana Moreira, Unidade Local de Saúde São João, Oporto
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07597174
- Sponsor's protocol ID
- CE-218-2024
- Status last verified
- May 2026
- First submitted
- 12 May 2026
- Last updated
- 22 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomized Controlled Non-Inferiority Trial Comparing a Mobile Application Based Program With Conventional Rehabilitation for Stress and Mixed Urinary Incontinence in Adult Women
- ClinicalTrials.gov ID
- NCT07597174
- Acronym / sponsor ID
- CE-218-2024
- Conditions
- Urinary Incontinence , Stress
- Keywords
- mobile app, urinary incontinence, woman
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 32 participants (estimated)
- Lead sponsor
- Unidade Local de Saúde São João, OportoOther government
- Study start
- 26 Mar 2026 (actual)
- Primary completion
- 21 Aug 2026 (estimated)
- Study completion
- 21 Aug 2026 (estimated)
- First posted
- 19 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if a mobile app-guided pelvic floor rehabilitation program works as well as standard in-person pelvic floor rehabilitation to treat urinary leakage in adult women.
The main question it aims to answer is:
Does the app program improve quality of life related to urinary leakage as much as in-person rehabilitation?
Researchers will compare the app-based program to in-person rehabilitation to see if both lead to similar improvements in quality of life.
Participants will:
Attend one medical visit before starting to confirm they are eligible Attend one in-person training session with a physiotherapist Follow either an app-based or an in-person pelvic floor rehabilitation program for 3 months Complete quality of life questionnaires at the start and at 4 months
Detailed description
Background
Urinary incontinence (UI) is common in women and undertreated in Portugal. Only 11% of Portuguese women with UI report having completed any rehabilitation program. Conventional pelvic floor rehabilitation requires supervised sessions two to three times per week for at least 3 to 4 months, mostly available only at tertiary hospitals. Mobile app-based programs may improve access, adherence, and convenience. However, no randomized trial has compared an app-based program directly against supervised rehabilitation as an active comparator in the Portuguese population. An important consideration in participant selection is pelvic floor muscle function. Studies show that up to 53% of women with UI cannot contract the pelvic floor correctly without prior in-person training. For this reason, the ability to voluntarily contract the pelvic floor is an inclusion criterion, confirmed at the baseline medical visit.
Study Design
This is a randomized controlled non-inferiority trial with two parallel arms conducted at the Pelvic Floor Rehabilitation Unit of the Physical and Rehabilitation Medicine (PM\&R) Department of ULS São João, a tertiary academic hospital in Porto, Portugal.
The Mobile App
The app-based program was developed by the investigators in collaboration with the Information Systems and Technologies Department and the Data Intelligence Department of ULS São João. It was integrated into the existing My São João App, a platform already in use by patients of the hospital. Prior to the trial, a preliminary version was tested over one month with 10 women with prior experience in supervised pelvic floor rehabilitation and with 4 clinicians specialised in pelvic floor rehabilitation. Participants completed a structured questionnaire assessing interface usability, aesthetics, engagement, and functionality, and took part in a discussion of weaknesses and suggestions for improvement. A final version was developed based on this feedback.
Randomization
After baseline assessment, participants are randomized 1:1 into the intervention or control group by a research assistant not involved in the investigation. Allocation uses a computer-generated random sequence implemented through sequentially numbered sealed opaque envelopes, stored in a locked cabinet accessible only to the research assistant. Envelopes are opened immediately before the initial individual session. Participants and health professionals are not blinded to group allocation.
Intervention Group - App-Based Program (12 weeks)
One in-person medical consultation at the start. Participants install the app, are trained on its use, and receive lifestyle and behavioural recommendations tailored to their UI type and baseline assessment results. Three in-person individual physiotherapy sessions at weeks 0, 4, and 8. At each session, participants are trained on the exercises that will be released on the app following that session. App content includes a structured pelvic floor muscle exercise program released in 3 progressive phases, with gradual increases in duration, repetitions, and positions. Participants perform a daily sequence 3 times per day and two 30-minute sessions per week. Programmable reminders allow participants to set exercise times according to their own schedule. Daily app notifications collect feedback on the number of sessions completed and participant satisfaction. One teleconsultation at week 6 to assess adherence, motivation, side effects, and progress. At week 12, participants are notified via the app to begin the maintenance phase: the daily sequence 3 times per day, 3 days per week. One in-person medical consultation at week 16 to assess compliance and outcomes.
Control Group - Supervised Program (12 weeks)
One in-person medical consultation at the start. Participants receive lifestyle and behavioural recommendations tailored to their UI type and baseline assessment results, and a written leaflet with a pelvic floor exercise sequence to perform 3 times per day. One initial in-person individual physiotherapy session, followed by supervised face-to-face group sessions twice per week (30 minutes each), structured in 3 progressive phases matching those of the app program. One in-person medical consultation at week 6 to assess adherence, side effects, and progress. At week 12, participants are instructed to begin the maintenance phase: 3 exercise sets, 3 days per week. One in-person medical consultation at week 16 to reassess compliance and outcomes.
Assessment Schedule
Outcomes are collected by physiatrists specialised in pelvic floor rehabilitation using a digital data collection form at three time points: baseline (week 0), mid-program (week 6), and end of follow-up (week 16).
Sample Size
Sample size was calculated using WinPepi version 11.65, assuming a significance level of 5%, statistical power of 80%, and a 1:1 allocation ratio. Based on a non-inferiority margin of 10.24 points on the King's Health Questionnaire (KHQ), with standard deviations of 10.545 (intervention) and 6.23 (control), 24 participants are required (12 per group). Accounting for an estimated 33% dropout rate, the target sample is 32 participants.
Statistical Analysis
Continuous variables will be described as means with standard deviations, or medians with interquartile ranges, depending on distribution. Categorical variables will be presented as proportions. Between-group comparisons at end of program will use the independent-samples t-test for normally distributed data, or the Mann-Whitney test otherwise. Categorical variables will be compared using the Chi-square or Fisher's exact test as appropriate. A pre-specified subgroup analysis will examine adherence and clinical improvement according to age, primary diagnosis (SUI or MUI), prior treatments, condition severity, quality of life scores, marital status, educational level, profession, smartphone operating system, duration of smartphone ownership, daily hours of use, and prior experience with health-related apps. A subsequent cost-effectiveness analysis is planned.
Ethical Considerations
The study is conducted in accordance with the ethical principles of the 1964 Declaration of Helsinki and its subsequent amendments. Participation is voluntary. Eligible participants are approached at their first consultation and given a participant information sheet and written informed consent form to take home. Signed consent is confirmed at the second appointment, two weeks later. Participants may withdraw at any time without consequence. All data are anonymised prior to analysis and stored securely with password protection. Only the participant's physiatrist has access to medical records. Results will be disseminated at scientific conferences and in peer-reviewed journals.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- randomized controlled non-inferiority trial with two parallel arms
| Arm | Type | Receives |
|---|---|---|
| Hybrid | Experimental | Other: Mobile app based rehabilitation protocolmobile app based treatment |
| conventional | Active comparator | Other: Presential rehabilitation programpresential |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- age >18 years
- stress urinary incontinence (SUI) or mixed urinary incontinence with predominance of SUI
- more than one urinary incontinence episode for week in the last month
- pelvic floor muscle strength equal or greater than 2 assessed by Oxford Modified Rating Score
Key exclusion criteria (10 listed)
- indwelling urinary catheter
- active pelvic neoplasia
- pelvic organ prolapse grade greater than or equal to 2
- active urinary tract infection or macroscopic hematuria
- neurogenic dysfunction of the lower urinary tract
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mobile app based rehabilitation protocolMobile app based rehabilitation protocol for Stress and Mixed Urinary Incontinence in Adult Women | Other | Hybrid |
| Presential rehabilitation programPresential rehabilitation program for Stress and Mixed Urinary Incontinence in Adult Women | Other | conventional |
Primary outcome
UI-related quality of life
Time frame: At baseline and in16 weeks
UI-related quality of life using the Portuguese version of the King´s Health Questionnaire (KHQ). KHQ is a disease-specific, self-administered questionnaire designed to assess the impact of UI on quality of life in women. The responses in KHQ have a four point rating system. The eight subscales ("domains") score between 0 (best) and 100 (worst). The Symptom Severity scale is scored from 0 (best) to 30 (worst). Decreases in KHQ domain scores indicate an improvement in quality of life. The minimally important difference - the smallest change in score that subjects perceive as beneficial - is 3 points for the symptom severity scale and 5 points for all other KHQ domains.
8 secondary outcomes
UI severity
Time frame: At baseline and in16 weeks
Perception of change
Time frame: At baseline and in16 weeks
Sexual function
Time frame: At baseline and in16 weeks
Symptoms of depression/anxiety
Time frame: At baseline and in 16 weeks
Health related quality of life
Time frame: At baseline and in 16 weeks
Satisfaction and adherence to treatment .
Time frame: At 16 weeks
Participants assessment of the app quality
Time frame: 16 weeks
Direct costs of urinary incontinence
Time frame: At baseline and in16 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 May 2026.
Related trials for Urinary Incontinence , Stress
RecruitingPhase 3
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Urinary Incontinence,Stress
Active, not recruitingObservational study
Return to Physical Activity After Retropublic Transvaginal Sling and Laparoscopic Sacrocolpopexy
Stress Urinary Incontinence, Pelvic Organ Prolapse
RecruitingPhase 1
Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old
Urinary Incontinence Stress
Recruiting
The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy
Prostate Cancer (Post Prostatectomy)
RecruitingObservational study
Standardized 4D Transperineal Ultrasound Assessment of Urethrovesical Junction Mobility After Vaginal Laser Treatment for Stress Urinary Incontinence.
Urinary Incontinence , Stress, Laser Therapy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mobile app based rehabilitation protocol and Presential rehabilitation program in people with Urinary Incontinence , Stress, run by Unidade Local de Saúde São João, Oporto at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 22 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Susana A Moreira, PMR specialist (+351917210578, s.moreira@ulssjoao.min-saude.pt), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
UI-related quality of life (time frame: At baseline and in16 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2026.